Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005930 | axoneme | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4QFC6
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 107 | 111 | PF00656 | 0.673 |
CLV_NRD_NRD_1 | 209 | 211 | PF00675 | 0.727 |
CLV_NRD_NRD_1 | 215 | 217 | PF00675 | 0.607 |
CLV_PCSK_KEX2_1 | 208 | 210 | PF00082 | 0.731 |
CLV_PCSK_PC7_1 | 205 | 211 | PF00082 | 0.700 |
CLV_PCSK_SKI1_1 | 151 | 155 | PF00082 | 0.520 |
CLV_PCSK_SKI1_1 | 4 | 8 | PF00082 | 0.644 |
DOC_USP7_MATH_1 | 141 | 145 | PF00917 | 0.677 |
DOC_USP7_MATH_1 | 192 | 196 | PF00917 | 0.761 |
DOC_WW_Pin1_4 | 117 | 122 | PF00397 | 0.736 |
DOC_WW_Pin1_4 | 199 | 204 | PF00397 | 0.730 |
LIG_14-3-3_CanoR_1 | 148 | 154 | PF00244 | 0.560 |
LIG_14-3-3_CanoR_1 | 163 | 168 | PF00244 | 0.512 |
LIG_14-3-3_CanoR_1 | 191 | 197 | PF00244 | 0.714 |
LIG_14-3-3_CanoR_1 | 20 | 30 | PF00244 | 0.530 |
LIG_FHA_2 | 123 | 129 | PF00498 | 0.775 |
LIG_LIR_Apic_2 | 84 | 89 | PF02991 | 0.665 |
LIG_LIR_Gen_1 | 94 | 104 | PF02991 | 0.552 |
LIG_LIR_Nem_3 | 94 | 99 | PF02991 | 0.641 |
LIG_Pex14_1 | 54 | 58 | PF04695 | 0.549 |
LIG_SH2_CRK | 96 | 100 | PF00017 | 0.632 |
LIG_SH2_GRB2like | 86 | 89 | PF00017 | 0.603 |
LIG_SH2_PTP2 | 86 | 89 | PF00017 | 0.657 |
LIG_SH2_SRC | 86 | 89 | PF00017 | 0.657 |
LIG_SH2_STAP1 | 96 | 100 | PF00017 | 0.539 |
LIG_SH2_STAT3 | 58 | 61 | PF00017 | 0.552 |
LIG_SH2_STAT5 | 157 | 160 | PF00017 | 0.530 |
LIG_SH2_STAT5 | 86 | 89 | PF00017 | 0.603 |
LIG_SH3_3 | 169 | 175 | PF00018 | 0.621 |
MOD_CDC14_SPxK_1 | 202 | 205 | PF00782 | 0.697 |
MOD_CDK_SPxK_1 | 199 | 205 | PF00069 | 0.702 |
MOD_CK1_1 | 106 | 112 | PF00069 | 0.585 |
MOD_CK1_1 | 149 | 155 | PF00069 | 0.666 |
MOD_CK1_1 | 193 | 199 | PF00069 | 0.729 |
MOD_CK1_1 | 33 | 39 | PF00069 | 0.551 |
MOD_CK2_1 | 122 | 128 | PF00069 | 0.758 |
MOD_CK2_1 | 192 | 198 | PF00069 | 0.778 |
MOD_GlcNHglycan | 143 | 146 | PF01048 | 0.653 |
MOD_GlcNHglycan | 148 | 151 | PF01048 | 0.612 |
MOD_GlcNHglycan | 172 | 175 | PF01048 | 0.696 |
MOD_GlcNHglycan | 192 | 195 | PF01048 | 0.697 |
MOD_GSK3_1 | 131 | 138 | PF00069 | 0.753 |
MOD_GSK3_1 | 170 | 177 | PF00069 | 0.649 |
MOD_GSK3_1 | 186 | 193 | PF00069 | 0.698 |
MOD_GSK3_1 | 29 | 36 | PF00069 | 0.574 |
MOD_NEK2_1 | 146 | 151 | PF00069 | 0.649 |
MOD_NEK2_1 | 197 | 202 | PF00069 | 0.719 |
MOD_NEK2_1 | 30 | 35 | PF00069 | 0.555 |
MOD_NEK2_1 | 95 | 100 | PF00069 | 0.462 |
MOD_PIKK_1 | 151 | 157 | PF00454 | 0.594 |
MOD_PIKK_1 | 30 | 36 | PF00454 | 0.625 |
MOD_PKA_2 | 190 | 196 | PF00069 | 0.759 |
MOD_PKB_1 | 161 | 169 | PF00069 | 0.682 |
MOD_Plk_4 | 95 | 101 | PF00069 | 0.529 |
MOD_ProDKin_1 | 117 | 123 | PF00069 | 0.740 |
MOD_ProDKin_1 | 199 | 205 | PF00069 | 0.729 |
TRG_ENDOCYTIC_2 | 229 | 232 | PF00928 | 0.518 |
TRG_ENDOCYTIC_2 | 96 | 99 | PF00928 | 0.631 |
TRG_ER_diArg_1 | 208 | 210 | PF00400 | 0.725 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I7F5 | Leptomonas seymouri | 49% | 100% |
A0A3Q8IDE0 | Leishmania donovani | 92% | 100% |
A0A3R7KEI8 | Trypanosoma rangeli | 31% | 100% |
A4H831 | Leishmania braziliensis | 73% | 100% |
A4HWF7 | Leishmania infantum | 92% | 100% |
C9ZNZ9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 30% | 100% |
E9AQ56 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |